Literature DB >> 2123067

Establishment and characterization of acute B-cell lymphocytic leukemia cell line showing (8;14) and (14;18) chromosome translocation.

H Matsuzaki1, H Hata, N Asou, H Suzushima, Y Akahoshi, M Yoshida, S Nagakura, T Ishii, I Sanada, K Takatsuki.   

Abstract

Cell line KHM-2B expressing two oncogene products, c-myc and bcl-2, was established from a patient with acute lymphocytic leukemia with an 8;14 and 14;18 chromosome translocation. Surface marker studies of the cell line showed that the cells were positive for HLA-DR, CALLA (CD10), B1 (CD20) and B4 (CD19), but negative for T11 (CD2). The fresh cells from peripheral blood of the patient had no surface immunoglobulins, whereas KHM-2B cells were positive for mu.lambda type surface immunoglobulin. A cytogenetic analysis of the cell line revealed two translocations, t (8;14) (q24;q32) and t(14;18)(q32;q21). Rearrangement of the c-myc and bcl-2 genes was detected by Southern blot analysis of the KHM-2B DNA. Northern blot analysis revealed production of c-myc and bcl-2 mRNAs. These results indicated that two oncogenes were activated by two translocations to immunoglobulin genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123067     DOI: 10.1159/000205054

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  7 in total

Review 1.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

2.  Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.

Authors:  H Hata; H Matsuzaki; F Matsuno; T Sonoki; S Takemoto; N Kuribayashi; A Nagasaki; K Takatsuki
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma.

Authors:  W Fiedler; H J Weh; W Zeller; C Fonatsch; J Hillion; C Larsen; B Wörmann; D K Hossfeld
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

4.  Establishment of a monoclonal antibody to human myeloma cell: relation to chemotherapy and extramedullar infiltration.

Authors:  N Kuribayashi; H Hata; H Matsuzaki; M Yoshida; T Sonoki; A Nagasaki; T Kimura; N Harada; K Takatsuki
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

5.  A human lymphoma cell line with multiple immunoglobulin rearrangements.

Authors:  H Chang; H A Messner; X H Wang; C Yee; L Addy; J Meharchand; M D Minden
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma.

Authors:  Elizabeth J Meredith; Michelle J Holder; Anders Rosén; Adrian Drake Lee; Martin J S Dyer; Nicholas M Barnes; John Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

7.  De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review.

Authors:  Akiko Uchida; Yasushi Isobe; Yu Uemura; Yuji Nishio; Hirotaka Sakai; Masayuki Kato; Kaori Otsubo; Masahiro Hoshikawa; Masayuki Takagi; Ikuo Miura
Journal:  BMC Clin Pathol       Date:  2017-11-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.